Published in:
01-12-2020 | Isoniazid | Case report
Isoniazid-induced gynaecomastia: report of a paediatric case and review of literature
Authors:
Sarah Wing Yiu Poon, Ka Ka Siu, Anita Man Ching Tsang
Published in:
BMC Endocrine Disorders
|
Issue 1/2020
Login to get access
Abstract
Background
Gynaecomastia is a fairly common condition in puberty but is rare in prepubertal boys. While it is necessary to exclude possible endocrinopathay in prepubertal gynaecomastia, medication is an important and potentially reversible cause to consider in new onset gynaecomastia. Isoniazid-induced gynaecomastia has been reported in adult males, but none was reported in the paediatric population and general paediatricians may not be aware of this uncommon side effect.
Case presentation
We hereby report a 11-year-old prepubertal boy who developed gynaecomastia while taking anti-tuberculosis drugs. Investigations excluded endocrinopathies. Gynaecomastia subsided 8 weeks after stopping isoniazid.
Conclusion
This case is the first paediatric case report describing the association of gynaecomastia with isoniazid use. It is important for general paediatricians to recognize this entity, as prompt diagnosis and cessation of the offending drug can lead to resolution of the problem.